Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc (NRXP)
1.8100 x 1 1.9700 x 4
Post-market by (Cboe BZX)
1.9800 +0.0700 (+3.66%) 04/23/25 [NASDAQ]
1.8100 x 1 1.9700 x 4
Post-market 1.8900 -0.0900 (-4.55%) 19:29 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.9301
Day High
2.0700
Open 1.9500
Previous Close 1.9100 1.9100
Volume 54,700 54,700
Avg Vol 129,150 129,150
Stochastic %K 60.71% 60.71%
Weighted Alpha -73.12 -73.12
5-Day Change +0.0100 (+0.51%) +0.0100 (+0.51%)
52-Week Range 1.1000 - 6.0100 1.1000 - 6.0100
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,310
  • Shares Outstanding, K 16,916
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,130 K
  • EBIT $ -20 M
  • EBITDA $ -20 M
  • 60-Month Beta 1.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 208.46% ( -206.72%)
  • Historical Volatility 84.20%
  • IV Percentile 57%
  • IV Rank 31.37%
  • IV High 612.53% on 12/05/24
  • IV Low 23.75% on 10/18/24
  • Put/Call Vol Ratio 1.43
  • Today's Volume 34
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 2,678
  • Open Int (30-Day) 2,931

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.74
  • Growth Rate Est. (year over year) +135,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +25.32%
on 04/07/25
Period Open: 2.0800
2.2000 -10.00%
on 03/24/25
-0.1000 (-4.81%)
since 03/21/25
3-Month
1.5800 +25.32%
on 04/07/25
Period Open: 2.9300
3.8300 -48.30%
on 01/28/25
-0.9500 (-32.42%)
since 01/23/25
52-Week
1.1000 +80.00%
on 10/16/24
Period Open: 3.0500
6.0100 -67.05%
on 01/13/25
-1.0700 (-35.08%)
since 04/23/24

Most Recent Stories

More News
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding

Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.

PSIL : 11.69 (+3.90%)
VXF : 165.44 (+1.85%)
NRXP : 1.9800 (+3.66%)
BIB : 44.35 (+3.02%)
Best Momentum Stocks to Buy for January 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6:NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has a Zacks Rank #1 and...

PDEX : 63.67 (+0.33%)
PBYI : 3.03 (+0.66%)
NRXP : 1.9800 (+3.66%)
New Strong Buy Stocks for January 6th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Alaska Air Group, Inc. ALK: This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing...

ALK : 46.11 (+2.60%)
PDEX : 63.67 (+0.33%)
NRXP : 1.9800 (+3.66%)
AHT : 6.00 (-1.48%)
EGAN : 4.76 (+3.93%)
Best Momentum Stocks to Buy for December 30th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:CoreCard Corporation CCRD: This technology solutions and processing services company...

NRXP : 1.9800 (+3.66%)
TRDA : 8.71 (unch)
CCRD : 19.60 (-0.91%)
New Strong Buy Stocks for December 30th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its...

APPN : 29.56 (+10.55%)
USNA : 25.43 (+4.91%)
NRXP : 1.9800 (+3.66%)
TRDA : 8.71 (unch)
CCRD : 19.60 (-0.91%)
New Strong Buy Stocks for December 26th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:eGain Corporation EGAN: This customer engagement solutions provider has seen the Zacks Consensus Estimate for its current year earnings...

BB : 3.29 (+3.79%)
NRXP : 1.9800 (+3.66%)
ACMR : 19.73 (+6.94%)
AVO : 10.65 (+1.62%)
EGAN : 4.76 (+3.93%)
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

NRXP : 1.9800 (+3.66%)
NRx Pharmaceuticals Announces Strategic Change in Development of NRX-100 (IV Ketamine) at Dawson James Small Cap Investor Conference

Previously announced data sharing agreement for intravenous ketamine Newly available data highlight the need for a labeled form of IV ketamine that can qualify...

NRXP : 1.9800 (+3.66%)
NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...

NRXP : 1.9800 (+3.66%)
NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug (IND) Application for NRX-101 to Treat Chronic Pain

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...

NRXP : 1.9800 (+3.66%)

Business Summary

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

See More

Key Turning Points

3rd Resistance Point 2.1965
2nd Resistance Point 2.1333
1st Resistance Point 2.0566
Last Price 1.9800
1st Support Level 1.9167
2nd Support Level 1.8535
3rd Support Level 1.7768

See More

52-Week High 6.0100
Fibonacci 61.8% 4.1344
Fibonacci 50% 3.5550
Fibonacci 38.2% 2.9756
Last Price 1.9800
52-Week Low 1.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective